Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Healthcare
Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen... see more

NDAQ:MNMD - Post Discussion

Mind Medicine (MindMed) Inc > Mark G. Gomez CO- Founder Canna Ventures Group LLC $MNMD
View:
Post by HampsStockstar on Jun 26, 2021 2:11am

Mark G. Gomez CO- Founder Canna Ventures Group LLC $MNMD

Gomez was quoted on Bloomberg radio as saying "psychedelic & mushroom space could see 5-10x returns from current levels". And cited $MNMD, $CLXP $LRSV $ATAI as his current favorites in the sector. Friday 25th $MNMD strong after recently added to Russell also the Peter Thiel back $ATAI IPO bring alot of attention to mushroom / psychedelic sp
Comment by SouthernTierTom on Jun 26, 2021 9:53am
Was anything mentioned about actually being "on" said meds in order to understand the valuation? It sounds like the next level of what we have seen up in Canada with the Great Canadien Pot Party....how is that working out for you? ; - ) At over 2 BILLION CAD...MNMD is already pricing in wondeful clinical success and one does wonder what the actual barriers to entry are to protect such ...more  
Mind Medicine (MindMed) Inc